重新回顾范式:无症状高度子宫内膜癌的诊断与改善结果无关
Ahmet Namazov1, Limor Helpman2, Ram Eitan3
1Barzilai University Medical Center, Ashkelon, Israel; Faculty of Health Sciences, Ben-Gurion University of Negev, Beer-Sheva, Israel.
概括
患有高度子宫内膜癌且出现绝经后出血的妇女的生存结果与无症状妇女相似. 这表明,对于诸如子宫内膜加厚等偶然发现,可能不需要进行常规的侵入性评估.
科学领域:
- 妇科瘤学 妇科瘤学
- 瘤外科手术 癌症外科手术
- 临床流行病学临床流行病学
背景情况:
- 高度子宫内膜癌的诊断可以发生在有症状或无症状的妇女中.
- 绝经后出血是一种常见的症状,促使对子宫内膜癌进行评估.
- 了解基于呈现症状的生存差异对于患者管理至关重要.
研究的目的:
- 为了比较患有高度子宫内膜癌的女性之间的生存结果,这些女性出现了绝经后出血,与那些无症状的女性相比.
- 为了确定是否出现症状会影响诊断时的疾病阶段或生存率.
主要方法:
- 一项多中心回顾性队列研究,涉及584名患有高度子宫内膜癌的女性.
- 使用卡普兰-梅尔和日志等级测试,比较无复发,疾病特异性和整体存活率.
- 通过考克斯回归分析评估复发和死亡的风险因素,重点关注绝经后出血作为主要暴露.
主要成果:
- 85.3%的妇女出现了绝经后出血;14.7%无症状.
- 两组之间5年无复发存活率 (70.1%对64.6%),疾病特异性存活率 (66.3%对64.2%) 或整体存活率 (56.4%对58%) 没有显著差异.
- 多变量分析发现绝经后出血和生存率之间没有显著的关联.
结论:
- 高度子宫内膜癌的无症状诊断与早期疾病阶段无关.
- 在无症状的妇女中,可能不需要进行例行侵入性评估,以检查诸如子宫内膜增厚或多等偶然发现.
- 高度子宫内膜癌的生存结果与症状呈现 (绝经后出血) 或无症状诊断无关,均可比较.
更多相关视频
05:52Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
Published on: August 19, 2021
13.0K
07:44Non-Invasive Ultrasound Assessment of Endometrial Cancer Progression in Pax8-Directed Deletion of the Tumor Suppressors Arid1a and Pten in Mice
Published on: February 17, 2023
2.0K
相关概念视频
Disorders of the Female Reproductive System
3.9K
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
3.9K
Cancer Survival Analysis
650
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
650
